Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreBringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE"Aligning legislative requirements, payer expectations regarding pricing and evidence, and meeting patients’ needs is now crucial for successful launches.
Learn moreExplore potential scenarios that the U.S. healthcare industry could face post COVID-19, and the strategies for where and how to compete in this evolving landscape.
This interactive e-book aims to assist U.S. pharma companies by providing insights into the most likely paths and how they can adapt their businesses for the post-pandemic world.
In this webinar, we'll explain what RWD is and show how you can access it for your state (no programming or coding required).
Find out the top issues affecting the pharmaceutical industry that have been exacerbated by the COVID-19 pandemic
A new year brings both challenges and opportunities for the MedTech industry
An exploration of the social determinants of health in the 8.5 million patients who missed a preventive care visit
As the Human Data Science company, we are committed to helping do what needs to be done to keep things moving healthcare forward. Patients must be treated. Trials must continue. Innovation and discovery must continue – not just to solve our current crisis but also to ensure we are ready to take on what comes next.